✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Abbott India Ltd.

ABBOTINDIA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹71,559 Cr.
P/E
50.59

Abbott India Ltd.

  • Abbott India
  • Aurobindo Pharma
  • Alkem Laboratories
  • TJI Pharma
FAQs on Abbott India Ltd. Shareprice

Abbott India has given better returns compared to its competitors.
Abbott India has grown at ~24.62% over the last 9yrs while peers have grown at a median rate of 8.46%

Yes, Abbott India is expensive.
Latest PE of Abbott India is 50.59, while 3 year average PE is 49.99.
Also latest EV/EBITDA of Abbott India is 41.27 while 3yr average is 37.03.

View FAQ's On Business
Growth Table
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Balance Sheet
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Cash Flow
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Quarterly Results
  • Abbott India Ltd.
  • Aurobindo Pharma
  • Alkem Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Abbott India Ltd. Financials

Balance sheet of Abbott India is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Abbott India is increasing.
Latest net debt of Abbott India is -₹3,255.84 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹4,268.98 Crs.

Yes, profit is increasing.
The profit of Abbott India is ₹1,414 Crs for Mar 2025, ₹1,201 Crs for Mar 2024 and ₹949 Crs for Mar 2023

The company seems to pay a good stable dividend.
Abbott India latest dividend payout ratio is 71.36% and 3yr average dividend payout ratio is 72.21%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech